Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc-dependent enzymes and transcription factors in immune cells constitute a broad class of proteins that utilize zinc ions for structural stability or catalytic activity (Bonaventura et al., 2015). This group includes critical enzymes like histone deacetylases (HDACs), which regulate gene expression through epigenetic modification, and matrix metalloproteinases (MMPs), which facilitate cell migration and tissue remodeling (Haberland et al., 2009). Additionally, numerous transcription factors, such as those containing zinc finger motifs (e.g., GATA-3, FOXP3), are vital for the lineage commitment and functional activation of T and B lymphocytes (Klug, 2010). Zinc deficiency or dysregulation of these proteins is strongly associated with impaired immune responses, chronic inflammation, and susceptibility to infections (Prasad, 2008). Pharmacological targeting of these molecules often involves small-molecule inhibitors that bind the zinc-containing active site, though the ubiquity of zinc-binding motifs presents significant challenges for achieving high selectivity (Haase & Rink, 2014). For instance, HDAC inhibitors are used in oncology and are being explored for autoimmune conditions, while zinc supplementation is a standard intervention for restoring immune function in deficient populations. Overall, these proteins serve as essential nodes in the signaling networks that govern both innate and adaptive immunity.
Drugs targeting zinc-dependent enzymes typically utilize a hydroxamate or carboxylate group to chelate the catalytic zinc ion, thereby preventing substrate binding and enzymatic activity (Haberland et al., 2009). For transcription factors, therapeutic strategies may involve modulating the availability of zinc or using small molecules to disrupt the zinc finger-DNA interface (Klug, 2010). Zinc supplements act by restoring the necessary cofactor levels for these proteins to function correctly in immune cell development and signaling (Prasad, 2008).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc-dependent enzymes and transcription factors in immune cells.